Sofinnova Investments, Inc. Glaukos Corp Transaction History
Sofinnova Investments, Inc.
- $1.63 Billion
- Q3 2025
A detailed history of Sofinnova Investments, Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 312,994 shares of GKOS stock, worth $28.2 Million. This represents 1.56% of its overall portfolio holdings.
Number of Shares
312,994Holding current value
$28.2 Million% of portfolio
1.56%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
351Shares Held
55.3MCall Options Held
163KPut Options Held
458K-
Black Rock Inc. New York, NY8.04MShares$724 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.58MShares$322 Million0.05% of portfolio
-
Primecap Management CO Pasadena, CA2.25MShares$203 Million0.15% of portfolio
-
State Street Corp Boston, MA2.1MShares$189 Million0.01% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.29B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...